• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


189.1200 USD 3.2800 1.76%

As of 20:10:00 ET on 10/24/2014.

Snapshot for Illumina Inc (ILMN)

Open: 185.8400 Day's Range: 185.8400 - 189.4200 Volume: 1,237,499
Previous Close: 185.8400 52wk Range: 91.0300 - 190.8580 1-Yr Rtn: +102.72%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 189.1200
  • 1D
  • 1M
  • 1Y
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 98.4847
Estimated P/E(12/2014) 71.8814
Relative P/E vs. SPX 5.6143
Earnings Per Share (USD) (ttm) 1.9203
Est. EPS (USD) (12/2014) 2.6310
Est. PEG Ratio 3.0168
Market Cap (M USD) 26,363.33
Shares Outstanding (M) 139.40
30 Day Average Volume 1,409,603
Price/Book (mrq) 20.6883
Price/Sale (ttm) 14.3565
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil